TCT 2025 | INVEST-CTO: Effectiveness and Safety of a Planned Investment Procedure in High-Risk CTO PCI

The success rate of percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains lower than for non-occlusive lesions, especially in complex CTOs. Furthermore, complications increase in prolonged and unsuccessful procedures, leading many CTO patients to be less frequently offered percutaneous revascularization.

When the initial attempt fails, a balloon dilation aimed at modifying the CTO is often performed, a strategy that has retrospectively shown to improve success rates in subsequent procedures.

The aim of the INVEST-CTO study was to determine whether, in patients with highly complex anatomical CTOs, a planned two-stage strategy—initial modification followed by a second procedure for complete recanalization—results in higher procedural success and improved safety.

The primary endpoint (PEP) was procedural success, defined as technical success without major adverse cardiac events (MACE: death, myocardial infarction, or clinically driven revascularization of the treated vessel). The secondary endpoint (SEP) was a 30-day safety composite.

Read also: TCT 2025 | INFINITY–SWEDEHEART: Long-Term Outcomes of the Bioadaptive Coronary Implant Versus Drug-Eluting Stent.

A total of 153 patients were analyzed, with a mean age of 66 years, predominantly male. The most common presentation was stable coronary artery disease. The mean J-CTO score was 4, indicating high complexity. The right coronary artery was most frequently involved (66%), followed by the left anterior descending (16%) and the circumflex (16%).

Regarding the PEP, the procedural success rate was 86.7% (95% CI 80.3–91.7; p < 0.05). For the SEP, the 30-day composite adverse event rate was 4.6%, suggesting a favorable safety profile.

Conclusion

A planned two-stage strategy for complex CTO intervention proved safe and effective. Initial modification of the CTO should be considered an early and rational approach in high-risk CTOs, with the potential to increase success rates and reduce complications.

Reference: Anja Øksnes, MD. TCT 2025.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Mechanical Aspiration versus Surgical Treatment of Tricuspid Valve Endocarditis

Tricuspid valve infective endocarditis (TVIE) accounts for approximately 5% to 10% of all cases of infective endocarditis. Surgical treatment remains the standard therapy in...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...